Kabra Drugs Ltd
company logo

Kabra Drugs Ltd

KABRADRUGS Share Price

BSE:524322

28.23

0.04 (0.14%)

As on April 17, 2026 at 04:00 PM
Loading chart...

Performance

Loading performance...

28.19

28.19

55694

0.16

10

Fundamentals

66.93Cr

15.60

2.57

0.08

1.81

0%

10.96

About

Kabra Drugs Limited was incorporated as a Limited Company on August 22, 1989. The Company has set up a Unit at Indore for manufacturing of Ether derivatives which includes Diethyl Ether (Anesthesia), Solvent Ether, Ethyl Chloride Spray (General Anesthesia) and Surgical. The commercial production commenced in 1991. Kabra Drugs Limited is the only manufacturer of Ether derivatives in the State of M.P. tHE Company is presently engaged in the business of Permaculture manufacturing and trading in pharma related products. The Company has 500+ products across India. The Company was incorporated with a mission to enrich the lives through pharmaceutical solutions which are innovative, high-quality and accessible to every family it serves. The latest addition to the product line is the range of disinfectants which includes hand wash gel, hand sanitizer and antimicrobial gel. In India there are very few manufacturers who are manufacturing the said products. The company is the sole manufacturer of antimicrobial hand wash gel and other disinfectant products in India. The company is also a registered supplier to the Ministry of Defence. Kabra Drugs are known to meet the diverse medical needs of patients in Emerging Markets in an innovative, socially responsible and commercially viable manner. Their products are manufactured at state of the art ultra modern plants with latest equipments backed by professional technocrats. The key strength comes from the development of new formulated speciality products, addressing critical therapeutic needs. Due to scarcity of working capital funds, the Company is not able to perform any business activities. To make the Company operational, the Board is making its best effort to implement the cost reduction measures to the extent feasible. Several cost cutting measures have been undertaken by the Company.

1989

NameDesignation
N AravindExecutive Director & MD
Venkatakrishnappa Ananth KumarExecutive Director / Whole Time Director / CFO
KUNIAMUTHUR NANJAPPAN ANANDExecutive Director
Ananthkumar ShilpaIndependent Director
A AnithaIndependent Director
Monika SanwalCompany Sec. & Compli. Officer

Kabra Drugs Ltd FAQs

How do I Buy Kabra Drugs Ltd Shares?

close

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Kabra Drugs Ltd shares in BlinkX.

What is the Share Price of Kabra Drugs Ltd?

close

The share price of any stock is volatile and changes during the day due to a variety of variables. Kabra Drugs Ltd's share price is ₹28.23 as of 2026-04-19.

What is the PE ratio of Kabra Drugs Ltd?

close

Kabra Drugs Ltd's P/E ratio is 15.6 times as of 2026-04-19.

What is the PB ratio of Kabra Drugs Ltd?

close

Kabra Drugs Ltd's most recent financial reports indicate a price-to-book ratio of 2.57, showing the company's stock market valuation in relation to the value of its real assets.

What is the Market Cap of Kabra Drugs Ltd?

close

Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Kabra Drugs Ltd's market capitalization is ₹66.93 Cr as on 2026-04-19.

What is the ROE of Kabra Drugs Ltd?

close

The current financial records of Kabra Drugs Ltd show a -% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

What is the Total Asset of Kabra Drugs Ltd?

close

According to Kabra Drugs Ltd's most recent financial filings, the company has a total asset value of ₹25.16, which includes current and non-current assets such as inventory, cash, properties, and equipment.

What is the 52-week high and Low of Kabra Drugs Ltd?

close

The 52-week high/low price of a Kabra Drugs Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Kabra Drugs Ltd's 52-week high and low as of 2026-04-19 are ₹35.52 and ₹10.56, respectively.